The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like BioTime Subsidiary AgeX Therapeutics, Inc. Appoints Ph.D. As VP Of New Technology Discovery July 12, 2017 Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position February 2, 2017 3 Depressed Biotechs that Investors with a Long-Term Perspective Should Buy Right Now April 11, 2016
BioTime Subsidiary AgeX Therapeutics, Inc. Appoints Ph.D. As VP Of New Technology Discovery July 12, 2017
Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position February 2, 2017
